|
Market Closed -
OTC Markets
14:17:26 2026-06-04 EDT
|
5-day change | 1st Jan Change | ||
| 0.0452 USD | -1.31% |
|
+13.00% | +126.00% |
| Market Cap | 5.07M 3.68M 3.15M 2.95M 2.7M 352M 5.13M 34.85M 13.59M 177M 13.82M 13.52M 585M | P/E 2024 |
-6.82x | P/E 2025 | -2.84x |
|---|---|---|---|---|---|
| Enterprise Value | 9.47M 6.87M 5.89M 5.51M 5.04M 658M 9.59M 65.1M 25.39M 330M 25.81M 25.25M 1.09B | EV / Sales 2024 |
1.15x | EV / Sales 2025 | 0.85x |
| Free-Float |
89.84% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.31% | ||
| 1 week | +13.00% | ||
| Current month | -8.50% | ||
| 1 month | +52.19% | ||
| 3 months | -30.46% | ||
| 6 months | +352.00% | ||
| Current year | +126.00% |
| 1 week | 0.02 | 0.05 | |
| 1 month | 0.02 | 0.05 | |
| Current year | 0 | 0.07 | |
| 1 year | 0 | 0.07 | |
| 3 years | 0 | 0.15 | |
| 5 years | 0 | 0.4 | |
| 10 years | 0 | 2.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Taz Turner
CEO | Chief Executive Officer | - | 2017-09-21 |
Ashish Kapoor
DFI | Director of Finance/CFO | 48 | 2015-03-09 |
Graeme Hawkins
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Taz Turner
CHM | Chairman | - | 2018-05-16 |
Benjamin Higham
BRD | Director/Board Member | - | 2020-04-07 |
Jakob Ripshtein
BRD | Director/Board Member | 60 | 2020-04-07 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/17/23 | Buy | Director | 30,000 | 0.0274% | ||
| 12/17/23 | Buy | Director | 500 | 0.0005% | ||
| 12/17/23 | Buy | Director | 500 | 0.0005% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.31% | +13.00% | -35.34% | -67.10% | 5.49M | ||
| 0.00% | +4.98% | -8.82% | +13.69% | 1.67B | ||
| +2.84% | +4.04% | +22.68% | +164.59% | 923M | ||
| -0.29% | +3.68% | -31.44% | +97.66% | 216M | ||
| +4.19% | +7.41% | -36.50% | -62.66% | 195M | ||
| +2.98% | +4.59% | -28.66% | +18.86% | 96.08M | ||
| Average | +1.40% | +3.90% | -19.68% | +27.51% | 518.35M | |
| Weighted average by Cap. | +1.18% | +4.74% | -3.44% | +59.50% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 13.8M 10.02M 8.58M 8.03M 7.35M 959M 13.98M 94.89M 37M 482M 37.63M 36.81M 1.59B | 14.25M 10.35M 8.86M 8.29M 7.59M 990M 14.44M 98M 38.22M 497M 38.86M 38.01M 1.65B |
| Net income | -1.49M -1.08M -929K -869K -795K -104M -1.51M -10.26M -4M -52.1M -4.07M -3.98M -172M | -2.69M -1.95M -1.67M -1.57M -1.43M -187M -2.73M -18.5M -7.22M -93.92M -7.34M -7.18M -311M |
| Net Debt | 5.66M 4.11M 3.52M 3.29M 3.01M 393M 5.73M 38.91M 15.17M 198M 15.43M 15.09M 653M | 4.4M 3.19M 2.74M 2.56M 2.34M 306M 4.46M 30.24M 11.79M 154M 11.99M 11.73M 508M |
Employees
-
Sector
Drug Retailers
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | US$0.0500 | -.--% | 2,790 |
- Stock Market
- Stocks
- LVRLF Stock
Select your edition
All financial news and data tailored to specific country editions
















